search
Back to results

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure

Primary Purpose

Respiratory Failure, Neuromuscular Disease, Chest Wall Disorder

Status
Withdrawn
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
AutoVPAP™
VPAPIIIST-A™
Sponsored by
ResMed
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Failure focused on measuring Acute exacerbation, Respiratory insufficiency, Respiratory failure, Hypercapnia, Hypoventilation, Sleep, Hypoxia, Titration, Non Invasive Ventilation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients admitted or transferred to Royal Brompton Hospital with acute exacerbation of chronic respiratory failure, or inpatients who suffer a deterioration in respiratory status, defined as 7.25 < pH < 7.35, PaCO2 > 6.0kPa, and respiratory rate > 20bpm

Exclusion Criteria:

  • < 18 years old
  • pH < 7.25
  • need for immediate intubation
  • uncontrolled cardiac failure
  • hypotensive (systolic blood pressure < 90mmHg)
  • acute myocardial infarction
  • acute dysrhythmia
  • other system failure (e.g. acute renal failure, liver failure)
  • moderate or severe bulbar weakness
  • inability to understand rationale and/or consent form for study

Sites / Locations

  • Royal Brompton Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

autotitrating NIV

Standard non-invasive ventilation

Arm Description

approximately 24 hours using autotitrating non-invasive ventilation for as many hours as possible whilst an inpatient in hospital

approximately 24 hours using standard non-invasive ventilation for as many hours as possible whilst an inpatient in hospital.

Outcomes

Primary Outcome Measures

pH at 1+ hour
pH of arterial blood after 1 hour of treatment with non-invasive ventialtion compared baseline value

Secondary Outcome Measures

pH at 4+ hours
pH of arterial blood after 4 hours of treatment with non-invasive ventialtion compared to baseline value
Respiratory Rate at 1+ hour
Respiratory rate after 1 hour of treatment with non-invasive ventilation compared to baseline value
Respiratory rate at 4+ hours
Respiratory rate after 4 hours of treatment with non-invasive ventilation compared to baseline value
overnight mean transcutaneous carbon dioxide
mean overnight transcutaneous carbon dioxide during sleep period
PaCO2 at 1+ hours
Carbon dixoide level of arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline
PaCO2 at 4+ hours
Carbon dioxide level in arterial blood after 4 hours of treatment with non-invasive ventilation compared to baseline value
PaO2 at 1+ hour
Oxygen level in arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline value
PaO2 at 4+ hours
Oxygen level in arterial blood after 4+ hours of treatment with non-invasive ventilation compared to baseline value

Full Information

First Posted
August 2, 2010
Last Updated
April 14, 2021
Sponsor
ResMed
Collaborators
Royal Brompton & Harefield NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT01174316
Brief Title
Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure
Official Title
Autotitrating Non-invasive Ventilation (NIV) Versus Standard NIV; a Randomised Crossover Trial in Patients With Acute Exacerbation of Chronic Respiratory Failure
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Withdrawn
Why Stopped
difficulty recruiting
Study Start Date
August 2010 (Actual)
Primary Completion Date
March 1, 2011 (Actual)
Study Completion Date
May 10, 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ResMed
Collaborators
Royal Brompton & Harefield NHS Foundation Trust

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients admitted to hospital with acute exacerbation of chronic respiratory failure. The investigators hypothesise that autotitrating NIV will ventilate patients with acute exacerbations of chronic respiratory failure as effectively as standard NIV.
Detailed Description
The aim of the study is to compare the effect of two types of noninvasive ventilator (a small machine that assists breathing) in patients admitted to hospital with a sudden worsening of their existing breathing insufficiency, including an increase of carbon dioxide in the blood (hypercapnia) and acidity of the blood. Noninvasive ventilation (NIV) is standard therapy for patients with acute hypercapnic exacerbations (sudden worsening of existing breathing insufficiency) of both chronic obstructive pulmonary disease (COPD) and nonCOPD patients. The most common type of NIV is bilevel pressure support which assists patient breathing by delivering different levels of air pressure during inspiration and expiration via a mask covering the nose or nose and mouth. Standard bilevel NIV (VPAP™) has been further developed to create a new automatically adjusting NIV (AutoVPAP™). Automatically adjusting NIV varies the inspiratory air pressure according to the airflow rates generated by the patient. This may improve patient comfort, hours of NIV use and recovery time. Patients over the age of 18 admitted to Royal Brompton Hospital respiratory ward will be considered for entry into this randomised crossover study. If eligible for inclusion and willing to take part patients will be setup on automatically adjusting NIV or standard NIV, assigned in random order. After 24 hours on the first NIV the patient will be swapped to the alternative NIV for a further 24 hours of treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Failure, Neuromuscular Disease, Chest Wall Disorder, Chronic Obstructive Pulmonary Disease, Obesity Hypoventilation Syndrome
Keywords
Acute exacerbation, Respiratory insufficiency, Respiratory failure, Hypercapnia, Hypoventilation, Sleep, Hypoxia, Titration, Non Invasive Ventilation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
autotitrating NIV
Arm Type
Experimental
Arm Description
approximately 24 hours using autotitrating non-invasive ventilation for as many hours as possible whilst an inpatient in hospital
Arm Title
Standard non-invasive ventilation
Arm Type
Active Comparator
Arm Description
approximately 24 hours using standard non-invasive ventilation for as many hours as possible whilst an inpatient in hospital.
Intervention Type
Device
Intervention Name(s)
AutoVPAP™
Other Intervention Name(s)
autotitrating variable positive airway pressure, autotitrating NIV, automatically titrating NIV
Intervention Description
Automatically titrated non-invasive ventilator, with target gross alveolar ventilation, end expiratory positive pressure, and back up respiratory rate determined by the clinician based on height and weight. The NIV must be used for as many hours as possible over the 24 hour period but breaks for meals, physiotherapy and bathroom are allowed.
Intervention Type
Device
Intervention Name(s)
VPAPIIIST-A™
Other Intervention Name(s)
standard NIV, standard non-invasive ventilator, variable positive airway pressure, VPAP
Intervention Description
Standard non-invasive ventilator, with inspiratory and expiratory positive pressure determined by the healthcare professional. The NIV must be used for as many hours as possible over the 24 hour period but breaks for meals, physiotherapy and bathroom are allowed.
Primary Outcome Measure Information:
Title
pH at 1+ hour
Description
pH of arterial blood after 1 hour of treatment with non-invasive ventialtion compared baseline value
Time Frame
1 hour
Secondary Outcome Measure Information:
Title
pH at 4+ hours
Description
pH of arterial blood after 4 hours of treatment with non-invasive ventialtion compared to baseline value
Time Frame
4+ hours of NIV treatment
Title
Respiratory Rate at 1+ hour
Description
Respiratory rate after 1 hour of treatment with non-invasive ventilation compared to baseline value
Time Frame
1+ hour of NIV treatment
Title
Respiratory rate at 4+ hours
Description
Respiratory rate after 4 hours of treatment with non-invasive ventilation compared to baseline value
Time Frame
4+ hours of NIV treatment
Title
overnight mean transcutaneous carbon dioxide
Description
mean overnight transcutaneous carbon dioxide during sleep period
Time Frame
24 hours
Title
PaCO2 at 1+ hours
Description
Carbon dixoide level of arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline
Time Frame
1+ hours of NIV treatment
Title
PaCO2 at 4+ hours
Description
Carbon dioxide level in arterial blood after 4 hours of treatment with non-invasive ventilation compared to baseline value
Time Frame
4+ hours of NIV treatment
Title
PaO2 at 1+ hour
Description
Oxygen level in arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline value
Time Frame
1+ hour of NIV treatment
Title
PaO2 at 4+ hours
Description
Oxygen level in arterial blood after 4+ hours of treatment with non-invasive ventilation compared to baseline value
Time Frame
4+ hours of NIV treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients admitted or transferred to Royal Brompton Hospital with acute exacerbation of chronic respiratory failure, or inpatients who suffer a deterioration in respiratory status, defined as 7.25 < pH < 7.35, PaCO2 > 6.0kPa, and respiratory rate > 20bpm Exclusion Criteria: < 18 years old pH < 7.25 need for immediate intubation uncontrolled cardiac failure hypotensive (systolic blood pressure < 90mmHg) acute myocardial infarction acute dysrhythmia other system failure (e.g. acute renal failure, liver failure) moderate or severe bulbar weakness inability to understand rationale and/or consent form for study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anita Simonds, MD, FRCP
Organizational Affiliation
Royal Brompton & Harefield Hospital NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal Brompton Hospital
City
London
ZIP/Postal Code
SW3 6NP
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure

We'll reach out to this number within 24 hrs